Abstracts

Citation

Mark Mirochnick, M.D., Ellen Rae Cooper, M.P.H., M.D., Jing Xu, M.S., Jane C. Lindsey, Sc.D., Edmund Capparelli, Pharm.D., Kenneth McIntosh, M.D., James McNamara, M.D., Lynne M. Mofenson, M.D., F.A.A.P. Population Pharmacokinetics Of Dapsone In HIV-Infected Children.

Citation

Joseph Chen, Jorge Pinto, Mark Mirochnick, Meredith Warshaw, Bonnie Zimmer, Vincent Carey, Betsy Smith, George Siberry, Tim R. Cressey, Stephen A. Spector , Edmund V. Capparelli for the IMPAACT P1083 Team. Population Pharmacokinetics of Lopinavir with WHO Weight Band Dosing - IMPAACT P1083. Presented at: ICAAC 2015; 2015 Sep 18.

Citation

Edmund Capparelli, Pharm.D., Suzette Blanchard, M.S., Ph.D., Francesca Aweeka, Pharm.D., Edward P. Acosta, Pharm.D. Population pharmacokinetics of nevirapine in infants and children - the impact of body size, age, and concomitant therapies. Presented at: 6th Int'l Workshop on Clinical Pharmacology of HIV Therapy.

Citation

A Bekker, N Hanan, A Violari, MF Cotton, B Graham, F Nakwa, EG Chadwick, T Ruel, M Mirochnick, E Capparelli. Population pharmacokinetics of nevirapine in preterm infants and prediction of doses needed for treatment in combination with other antiretrovirals. Presented at: 37th European Society for Paediatric Infectious Diseases.

Citation

Jennifer R. King, Pharm.D. Population pharmacokinetics of tenofovir in HIV-infected children and adolescents. Presented at: 10th Int'l Workshop on Clinical Pharmacology of HIV Therapy.

Citation

Population Pharmacokinetics of Twice Daily Zidovudine (ZDV) in HIV-Infected Children: A Pooled Analysis from 6 international studies and an assessment of ZDV exposure following WHO weight band recommendations.

Citation

J Li, M Nikanjam, C Cunningham, E McFarland, J Ledgerwood, J Mascola, B Graham, E Capparelli. Population Pharmacokinetics of VRC01 in Infants and Adults. Presented at: 20th International Workshop on Clinical Pharmacology of HIV Hepatitis & Other Antiviral Drugs Conference.

Citation

Richard Brundage, Pharm.D., Ph.D., E. Richard Stiehm, M.D., Joette Lambert, R.N., B.S.N., J. Ng, Martha Hering, D. Robert Harris, Ph.D., John ( Jack ) Moye, Jr., M.D., Lynne M. Mofenson, M.D., F.A.A.P., Courtney V. Fletcher, Pharm.D. Population pharmacokinetics of zidovudine (ZDV) in HIV-exposed neonates. Presented at: 8th Conference on Retroviruses & Opportunistic Infections.

Citation

Safa A. Algharbi, Marlon J. Liyanage, Mark Mirochnick, Brookie M. Best, Emily Barr, Alice Stek, Kristina M. Brooks, Sandra Burchett, Kathleen M. Powis, Tim Cressey, Edmund V. Capparelli, Jeremiah D. Momper. Population PK and CYP3A Inhibition Capacity of Ritonavir in Pregnancy: A Model-Based Meta-Analysis.

Citation

Marilyn Jean Crain, M.P.H., M.D., Miriam Chernoff, Ph.D., James M. Oleske, M.D., Susan Brogly, Ph.D., Kathleen Malee, Ph.D., Peggy R. Borum, Ph.D., Wendy G Mitchell, M.D., Heather Ford-Chatterton, B.S.N., Russell B. Van Dyke, M.D., George Seage, III, Sc.D., M.P.H. Possible mitochondrial dysfunction in a large U.S. cohort of HIV-infected children. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.